These results indicate that the TGF-β–Sox4–Sox2 pathway is essential for retaining the stemness of GICs, and inhibition of TGF-β signaling may be a potential method for treating glioma through targeting GICs (Figure 4). This evidence concerns the gene TGFB1 and glioma.